A Sage view of mesenchymal stem cells

International Journal of Stem Cells

Volumn 2, Issue 1, 2009, Pages 1-10

  Phinney, Donald G ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Marrow stromal cells; Mesenchymal stem cells; Multi potent mesenchymal progenitor cells; Serial analysis of gene expression

Indexed keywords

EID: 80051577126     PISSN: 20053606     EISSN: 20055447     Source Type: Journal    
DOI: 10.15283/ijsc.2009.2.1.1     Document Type: Review

References (40)

1. Phinney DG. Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl 2002;38:7-12.
2. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977;91:335-344.
3. Gartner S, Kaplan H. Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A 1980;77:4756-4759.
4. Phinney DG. Marrow stem cells. In: Polak J, editor. Advances in Tissue Engineering. London: Imperial College Press; 2008. 95-122.
5. Beresford JN, Bennet JH, Devlin C, Leboy PS, Owen ME. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992;102:341-351.
6. Umezawa A, Maruyama T, Segawa K, Shadduck RK, Waheed A, Hata JI. Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J Cell Physiol 1992;151:197-205.
7. Caplan AI. The mesengenic process. Clin Plast Surg 1994;21:429-435.
8. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999;14:700-709.
9. Pittenger MF, MacKay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
10. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999;107:275-281.
11. Mauraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166.
12. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997;12:1335-1347.
13. Miller-Sieburg C, Deryugina E. The stromal cells' guide to the stem cell universe. Stem Cells 1985;13:477-486.
14. Pittenger MF, Mbalaviele G, Black M, Mosca JD, Marshak DR. 2001. Mesenchymal stem cells. In: Koller MR, Palsson BO, Master JRW, editors. Human Cell Culture. Great Britian: Kluwer Academic Publishers; 189-207.
15. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Expt Hematol 2002;30:783-791.
16. Buhring HJ, Battula VL, Trem S, Schewe B, Kanz L, Vogel W. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 2007;1106:262-271.
17. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identified mesenchymal stem cells from bone marrow. Blood 2007;109:1743-1751.
18. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007;131:324-336.
19. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
20. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003;89:1235-1249.
21. Phinney DG. 2008. Isolation of murine mesenchymal stem cells by immunodepletion. In: Prockop DJ, Bunnell BA, Phinney DG, editors. Methods in Molecular Biology, Molecular Medicine and Biotechnology: Adult Mesenchymal Stem Cells. Totowa NJ: Humana Press Inc; 171-186.
22. Tremain N, Korkko J, Ibberson D, Kopen GC, DiGirolamo C, Phinney DG. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells 2001;19:408-418.
23. Phinney DG. 2006. Gene expression profiles of mesenchymal stem cells. In: Nolta JA, editor. Genetic Engineering of Mesenchymal Stem Cells. The Netherlands: Springer; 59-80.
24. Phinney DG, Hill K, Michelson C, DuTreil M, Hughes C, Humphries S, Wilkinson R, Baddoo M, Bayly E. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells 2006; 4:186-198.
25. Kopen G, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999;96:10711-10716.
26. Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Design 2005;11:1255-1265.
27. Jeun SS. Clinical application of mesenchymal stem cells for CNS disease. 5th Catholic International Stem Cell Symposium Proceedings, Seoul, Korea 2007; pp48-49.
28. McBride C, Gaupp D, Phinney DG. Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR. Cytotherapy 2003;5:7-18.
29. Phinney DG, Baddoo M, Gaupp D, DuTreil M, Isakova IA. Murine MSCs transplanted to the CNS of neonatal vs. adult mice exhibit distinct engraftment kinetics and express receptors that guide neuronal cell migration. Stem Cell Dev 2006;15:437-447.
30. Isakova IA, Baker K, Dufour J, Gaupp D, Phinney DG. Preclinical evaluation of adult stem cell engraftment and toxicity in the CNS of rhesus macaques. Mol Therapy 2006;13:1173-1184.
31. Isakova IA, Baker K, Dufour J, Gaupp D, Phinney DG. Ageand dose related effects on MSC engraftment levels and anatomical distribution in the CNS of nonhuman primates: identification of novel MSC subpopulations that respond to guidance cues in brain. Stem Cells 2007;25:3261-3270.
32. Matter ML, Ruoslahti E. A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription. J Biol Chem 2001;276:27757-27763.
33. Cheng SL, Shin CS, Towler DA, Civitelli R. A dominant negative cadherin inhibits osteoblast differentiation. J Bone Miner Res 2000;15:2362-2370.
34. Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H, Bacon KB, Jiang Zh, Zhang Xc, Rao Y. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001;410:948-952.
35. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003;100:8407-8411.
36. Ortiz LA, DuTreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. Interleukin 1 receptor antagonist mediates the anti-inflammatory and anti-fibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007;104:11002-11007.
37. Rochefort GY, Vaudin P, Bonnet N, Pages JC, Domenech J, Charbord P, Eder V. Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies? Respir Res 2005;6:125.
38. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first pass effect. Stem Cells Dev 2008[Epub ahead of print].
39. Juge-Aubry CE, Somm E, Chicheportiche R, Burger D, Pernin A, Cuénod-Pittet B, Quinodoz P, Giusti V, Dayer JM, Meier CA. Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrin Metab 2004;89:2652-2658.
40. Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle 2007;6:2884-2889.